Improved diagnostics in invasive aspergillosis and systematic monitoring in patients at high risk of infection;Verbeterde diagnostiek van invasieve aspergillose en systematische controle bij patiënten met een verhoogd risico

Nederlands Tijdschrift voor Geneeskunde

Volumn 149, Issue 11, 2005, Pages 561-567

  Verweij, P E ^a   Donnelly, J P ^a   Van Die, C E ^a   Blijlevens, N M A ^a   Kullberg, B J ^a   De Pauw, B E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOMANNAN;

ASPERGILLOSIS; ASPERGILLUS; DIAGNOSTIC PROCEDURE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HIGH RISK PATIENT; HUMAN; IMMUNE DEFICIENCY; INVASIVE ASPERGILLOSIS; PATIENT MONITORING; REVIEW; THORAX RADIOGRAPHY;

ASPERGILLOSIS; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOCOMPROMISED HOST; MANNANS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 15244363850     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Warns A, Gaustad P, Meis JF, Voss A, Verweij PE, Abrahamsen TG. Recovery of filamentous fungi from water in a paediatric bone marrow transplantation unit. J Hosp Infect 2001;47:143-8.
2. Wald A, Leisenring W, Burik JA van, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997;175:1459-66.
3. Patterson TF, Kirkpatrick WR, White M, Hiemenz, JW, Wingard JR, Dupont B, et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. 13 Aspergillus Study Group. Medicine (Baltimore) 2000;79:250-60.
4. Warris A, Bjorneklett A, Gaustad P. Invasive pulmonary aspergillosis associated with infliximab therapy. N Engl J Med 2001;344:1099-100.
5. Ascioglu S, Pauw BE de, Donnelly JP, Collette L. Reliability of clinical research on invasive fungal infections: a systematic review of the literature. Med Mycol 2001;39:35-40.
6. Ascioglu S, Rex JH, Pauw BE de, Bennett JE, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immuno-compromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Clin Infect Dis 2002;34:7-14.
7. Husain S, Alexander BD, Munoz P, Avery RK, Houston S, Pruett T, et al. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis 2003;37:221-9.
8. Von Eiff M, Roos N, Fegeler W, von Eiff C, Schulten R, Hesse M, et al. Hospital-acquired Candida and Aspergillus pneumonia - diagnostic approaches and clinical findings. J Hosp Infect 1996;32:17-28.
9. Becker MJ, Lugtenburg EJ, Cornelissen JJ, Schee C van der, Hoogsteden HC, Marie S de. Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br J Haematol 2003;121:448-57.
10. Verweij PE, Brinkman K, Kremer HP, Kullberg BJ, Meis JF. Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management. J Clin Microbiol 1999;37:1186-9.
11. Maertens J, Eldere J van, Verhaegen J, Verbeken E, Verschakelen J, Boogaerts M. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 2002;186:1297-306.
12. Boutboul F, Alberti C, Leblanc T, Sulahian A, Gluckman E, Derouin F, et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease. Clin Infect Dis 2002;34:939-43.
13. Sulahian A, Touratier S, Ribaud P. False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N Engl J Med 2003;349:2366-7.
14. Odabasi Z, Mattiuzzi G, Estey E, Kantarjian H, Saeki F, Ridge RJ, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004;39:199-205.
15. Einsele H, Hebart H, Roller G, Loffler J, Rothenhofer I, Muller CA, et al. Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol 1997;35:1353-60.
16. Hebart H, Loffler J, Meisner C, Serey F, Schmidt D, Bohme A, et al. Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening. J Infect Dis 2000;181:1713-9.
17. Caillot D, Casasnovas O, Bernard A, Couaillier JF, Durand C, Cuisenier B, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997;15:139-47.
18. Franquet T, Muller NL, Gimenez A, Guembe P, de la Torre J, Baque S. Spectrum of pulmonary aspergillosis: histologic, clinical, and radiologic findings. Radiographies 2001;21:825-37.
19. Spronsen DJ van, Daenen SMGJ, Kluin-Nelemans JC. Diagnose in beeld (92). Een man met koorts tijdens chemotherapie. Ned Tijdschr Geneeskd 2002;146:1126.
20. Walree NC van. Diagnose in beeld (167). Een hoestende vrouw met afwijkingen op de thoraxröntgenfoto. Ned Tijdschr Geneeskd 2003; 147:2375.
21. Severens JL, Donnelly JP, Meis JF, Vries Robbé PF de, Pauw BE de, Verweij PE. Two strategies for managing invasive aspergillosis: a decision analysis. Clin Infect Dis 1997;25:1148-54.